AstraZeneca Says Safe Harbor Dooms Crestor Patent Suit

Law360, New York (October 24, 2013, 6:18 PM EDT) -- AstraZeneca Pharmaceuticals LP urged a South Carolina federal judge Wednesday to toss a patent infringement suit facing the drugmaker over a clinical trial for Crestor, saying its actions during the trial were protected by a safe harbor provision and there was no proof the company infringed the patents afterward.

AstraZeneca said its experimental use of Crestor, a drug used to treat high cholesterol, to treat another health condition during the trial was lawful because it was part of a U.S. Food and Drug Administration application. Plus,...
To view the full article, register now.